Cargando…
Extra-Neural Metastases of Malignant Gliomas: Myth or Reality?
Malignant gliomas account for approximately 60% of all primary brain tumors in adults. Prognosis for these patients has not significantly changed in recent years— despite debulking surgery, radiotherapy and cytotoxic chemotherapy—with a median survival of 9–12 months. Virtually no patients are cured...
Autor principal: | Beauchesne, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756372/ https://www.ncbi.nlm.nih.gov/pubmed/24212625 http://dx.doi.org/10.3390/cancers3010461 |
Ejemplares similares
-
Fotemustine: A Third-Generation Nitrosourea for the Treatment of Recurrent Malignant Gliomas
por: Beauchesne, Patrick
Publicado: (2012) -
Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?
por: Nerone, Marta, et al.
Publicado: (2022) -
Polyacetylene: Myth and Reality
por: Hudson, Bruce S.
Publicado: (2018) -
Unicorn. Myth and reality
Publicado: (1978) -
Myth or Reality—Transdermal Magnesium?
por: Gröber, Uwe, et al.
Publicado: (2017)